These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 1032007)

  • 21. Short-term stimulation by propranolol and verapamil of cardiac cellular autophagy.
    Bahro M; Pfeifer U
    J Mol Cell Cardiol; 1987 Dec; 19(12):1169-78. PubMed ID: 3443984
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The specificity of action of penbutolol and propranolol and their optical isomers].
    Kaiser J
    Arzneimittelforschung; 1980; 30(3):427-32. PubMed ID: 6104494
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Proceedings: Possible explanation for protective action of long-term beta-adrenoceptor blockade after myocardial infarction.
    Raine AE; Williams EM
    Br Heart J; 1976 Aug; 38(8):873-4. PubMed ID: 9949
    [No Abstract]   [Full Text] [Related]  

  • 24. Morphometric changes in rabbit ventricular myocardium produced by long-term beta-adrenoceptor blockade.
    Williams EM; Tasgal J; Raine AE
    Lancet; 1977 Oct; 2(8043):850-2. PubMed ID: 72197
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of beta-adrenergic blocking activities of propranolol, isopropylmethoxamine, sotalol, practolol, alprenolol, pindolol, oxprenolol and D-32 in the atria and trachea of the guinea-pig.
    Horii D; Kawada T; Takeda K; Imai S
    Arzneimittelforschung; 1974 Sep; 24(9):1275-7. PubMed ID: 4154764
    [No Abstract]   [Full Text] [Related]  

  • 26. Proceedings: Two types of intrinsic sympathomimetic activity with beta-adrenoceptor blocking drugs.
    Bilski A; Wale J; Dawes PM
    Br J Pharmacol; 1976 Mar; 56(3):362P. PubMed ID: 4182
    [No Abstract]   [Full Text] [Related]  

  • 27. [Protection of oxyphenamone on myocardium against ischemia-reperfusion injury in rat heart].
    Fan LL; Teng J; Zhang RD; Zhao DY
    Yao Xue Xue Bao; 2005 Jun; 40(6):507-12. PubMed ID: 16144314
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Coronary and systemic hemodynamic effects of propranolol and practolol compared in the resting, conscious dog.
    Andres JF; White FC; Bloor CM
    Res Commun Chem Pathol Pharmacol; 1974 Feb; 7(2):481-4. PubMed ID: 4818387
    [No Abstract]   [Full Text] [Related]  

  • 29. Effect of cardioselective beta-blockade by metoprolol on the phasic myocardial blood content and epi/endocardial ratio.
    Virtanen K; Frick MH
    Ann Clin Res; 1977 Apr; 9(2):97-9. PubMed ID: 883763
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparative study of beta andreoceptor antagonists on the isolated atria of control and of the reserpine treated rabbits.
    Hague MA; Darabi MK; Khalighi MR
    Pahlavi Med J; 1977 Jul; 8(3):326-44. PubMed ID: 21372
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A test which may demonstrate in man, intrinsic sympathomimetic activity of beta-adrenoceptor blocking drugs [proceedings].
    Harry JD; Knapp MF; Linden RJ; Newcombe CP; Stoker JB
    Br J Clin Pharmacol; 1975 Aug; 2(4):374P. PubMed ID: 9951
    [No Abstract]   [Full Text] [Related]  

  • 32. Changes in myocardial collagen in normal development and after beta blockade.
    Caspari PG; Gibson K; Harris P
    Recent Adv Stud Cardiac Struct Metab; 1975; 7():99-104. PubMed ID: 1226461
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intravenous beta-blockade in coronary heart disease: is cardioselectivity or intrinsic sympathomimetic activity hemodynamically useful?
    Taylor SH; Silke B; Lee PS
    N Engl J Med; 1982 Mar; 306(11):631-5. PubMed ID: 6120457
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Differentiation between beta adrenergic and Ca 2+ antagonistic influencing components of beta receptor blockaders in the myocardium and in smooth muscles with special reference to Trasicor].
    Grün G; Byon KY; Kaufmann R; Fleckenstein A
    Arztl Forsch; 1972 Nov; 26(11):369-78. PubMed ID: 4404592
    [No Abstract]   [Full Text] [Related]  

  • 35. A comparative study of the effects of metipranolol, propranolol, alprenolol, oxprenolol, pindolol and practolol on the circulation in experimental animals.
    Trcka V; Vanĕcek M; Helfert I; Mácová S
    Acta Univ Carol Med (Praha); 1980; 26(5-6):239-58. PubMed ID: 6126104
    [No Abstract]   [Full Text] [Related]  

  • 36. [Polycardiographic evaluation of the modifications in the heart inotropism induced by propranolol and practolol].
    Giani P; Cameroni E; Fantola E; Folli G; Radice M
    Boll Soc Ital Cardiol; 1972; 17(10):858-64. PubMed ID: 4681408
    [No Abstract]   [Full Text] [Related]  

  • 37. [Differentiation between real and apparent beta receptor blockade in the heart].
    Bartsch W; Roesch E; Heboid G; Dietz E
    Arzneimittelforschung; 1974 Mar; 24(3):303-8. PubMed ID: 4152169
    [No Abstract]   [Full Text] [Related]  

  • 38. cAMP activity and isoproterenol-induced myocardial injury in rats.
    Bhagat B; Sullivan JM; Fischer VW; Nadel EM; Dhalla NS
    Recent Adv Stud Cardiac Struct Metab; 1976 May 26-29; 12():465-70. PubMed ID: 202000
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Effects of propranolol and practolol on exercise-induced changes in the dynamics of left ventricle contractions].
    Goch JH
    Wiad Lek; 1974 Jan; 27(2):119-22. PubMed ID: 4600841
    [No Abstract]   [Full Text] [Related]  

  • 40. [The nature of differences in beta-adrenergic receptors].
    Abrmets II; Simon IB
    Biull Eksp Biol Med; 1975 May; 79(5):11-4. PubMed ID: 1227580
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.